Sutro Biopharma Inc banner

Sutro Biopharma Inc
NASDAQ:STRO

Watchlist Manager
Sutro Biopharma Inc Logo
Sutro Biopharma Inc
NASDAQ:STRO
Watchlist
Price: 15.535 USD 11.12% Market Closed
Market Cap: $132.4m

Relative Value

The Relative Value of one STRO stock under the Base Case scenario is hidden USD. Compared to the current market price of 15.535 USD, Sutro Biopharma Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

STRO Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

STRO Competitors Multiples
Sutro Biopharma Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Sutro Biopharma Inc
NASDAQ:STRO
119m USD 1.2 -0.6 0.3 0.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 643 258.8 -159 901.4 -194 171.3 -191 955.6
US
Abbvie Inc
NYSE:ABBV
395.5B USD 6.6 168.3 16.3 23.1
US
Amgen Inc
NASDAQ:AMGN
198.2B USD 5.4 25.5 14.7 14.7
US
Gilead Sciences Inc
NASDAQ:GILD
184.1B USD 6.3 22.7 15.4 15.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.1B USD 10.1 32.1 23.6 24.6
US
Epizyme Inc
F:EPE
94.1B EUR 2 094 -534.3 -581.8 -566.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80B USD 5.6 17.8 13.2 15.1
AU
CSL Ltd
ASX:CSL
78B AUD 3.5 18.1 12.3 15.3
NL
argenx SE
XBRU:ARGX
42.6B EUR 14.2 33.3 56.8 58.4
US
Seagen Inc
F:SGT
39.3B EUR 20.2 -61.8 -66.7 -60.2
P/S Multiple
Revenue Growth P/S to Growth
US
Sutro Biopharma Inc
NASDAQ:STRO
Average P/S: 3 058 675.1
1.2
-6%
N/A
FR
Pharnext SCA
OTC:PNEXF
33 643 258.8
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.6
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
5.4
2%
2.7
US
Gilead Sciences Inc
NASDAQ:GILD
6.3
4%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.1
10%
1
US
E
Epizyme Inc
F:EPE
2 094
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.6
9%
0.6
AU
CSL Ltd
ASX:CSL
3.5
5%
0.7
NL
argenx SE
XBRU:ARGX
14.2
49%
0.3
US
S
Seagen Inc
F:SGT
20.2
30%
0.7
P/E Multiple
Earnings Growth PEG
US
Sutro Biopharma Inc
NASDAQ:STRO
Average P/E: 45.4
Negative Multiple: -0.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -159 901.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
168.3
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.5
18%
1.4
US
Gilead Sciences Inc
NASDAQ:GILD
22.7
192%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
32.1
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
13%
1.4
AU
CSL Ltd
ASX:CSL
18.1
11%
1.6
NL
argenx SE
XBRU:ARGX
33.3
42%
0.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Sutro Biopharma Inc
NASDAQ:STRO
Average EV/EBITDA: 19.1
0.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 171.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.3
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.7
10%
1.5
US
Gilead Sciences Inc
NASDAQ:GILD
15.4
7%
2.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.6
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581.8 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.2
23%
0.6
AU
CSL Ltd
ASX:CSL
12.3
8%
1.5
NL
argenx SE
XBRU:ARGX
56.8
810%
0.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.7 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Sutro Biopharma Inc
NASDAQ:STRO
Average EV/EBIT: 20.9
0.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -191 955.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.1
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
14.7
2%
7.3
US
Gilead Sciences Inc
NASDAQ:GILD
15.4
13%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.6
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -566.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.1
21%
0.7
AU
CSL Ltd
ASX:CSL
15.3
11%
1.4
NL
argenx SE
XBRU:ARGX
58.4
N/A N/A
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.2 N/A N/A